Tanja Gardlowski

Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.

A. Schambach, S. Klöss, L. Arseniev, 2017, Human gene therapy.

Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset

M. Heuser, L. Arseniev, U. Köhl, 2017, Front. Immunol..

IL‐2‐activated haploidentical NK cells restore NKG2D‐mediated NK‐cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA

J. Koch, J. Passweg, T. Klingebiel, 2010, European journal of immunology.

Clinical Grade Purification and Expansion of NK Cell Products for an Optimized Manufacturing Protocol

J. Passweg, S. Zimmermann, T. Klingebiel, 2013, Front. Oncol..

Preclinical Assessment of Suitable Natural Killer Cell Sources for Chimeric Antigen Receptor Natural Killer-Based "Off-the-Shelf" Acute Myeloid Leukemia Immunotherapies.

A. Schambach, M. Heuser, Johann Meyer, 2019, Human gene therapy.

Cetuximab Reconstitutes Pro-Inflammatory Cytokine Secretions and Tumor-Infiltrating Capabilities of sMICA-Inhibited NK Cells in HNSCC Tumor Spheroids

J. Koch, S. Klöss, M. Morgan, 2015, Front. Immunol..

Increased sMICA and TGFβ1 levels in HNSCC patients impair NKG2D-dependent functionality of activated NK cells

J. Koch, S. Klöss, L. Arseniev, 2015, Oncoimmunology.